Wegovy 2.4 mg (Semaglutide) Injection

Description

Take full control of your weight loss journey with the Wegovy 2.4 mg Pen, the final and full maintenance dose in the semaglutide titration schedule. Clinically proven to help patients lose a significant percentage of their body weight, this once-weekly injection delivers powerful appetite regulation and long-term support for sustainable weight management.

💊 Key Features of Wegovy 2.4 mg

• Contains 2.4 mg of semaglutide per injection

• Recommended for long-term maintenance after completing dose escalation

• Maximizes hunger suppression and weight loss outcomes

• Once-weekly subcutaneous injection

• Used alongside a reduced-calorie diet and increased physical activity

📦 What’s Included

• 1 x Wegovy 2.4 mg prefilled pen (4 weekly doses)

• 4 pen needles

• User instructions

• Secure, discreet shipping

🌟 Benefits

• Provides maximum appetite control and satiety

• Helps maintain steady long-term weight loss

• May improve blood sugar regulation, blood pressure, and cholesterol levels

• Supports lifestyle changes with biological reinforcement

• May reduce risks of obesity-related health conditions such as type 2 diabetes, heart disease, and sleep apnea

🩺 How to Use

• Inject once a week, on the same day each week

• Use a different injection site each time (abdomen, thigh, or upper arm)

• Do not mix with other medications in the same injection

• If switching from a lower dose, begin 2.4 mg after completing at least 4 weeks on 1.7 mg

⚠️ Safety Information / Warnings

• For use by adults with BMI ≥30, or ≥27 with weight-related health conditions

• Not recommended for individuals with a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Common side effects: nausea, vomiting, diarrhea, constipation, fatigue, abdominal pain

• May cause low blood sugar when used with insulin or other diabetes medications

• Talk to your doctor before use if you have had pancreatitis, gallbladder disease, or kidney issues

• Not safe for use during pregnancy or while breastfeeding

❄️ Storage & Handling

• Store unused pens in the refrigerator (2°C to 8°C / 36°F to 46°F)

• Once in use, pens may be stored at room temperature (up to 30°C / 86°F) for up to 28 days

• Do not freeze; discard if frozen

• Protect from excessive heat and direct sunlight

• Keep out of reach of children

❓ Frequently Asked Questions

Q: What results can I expect at the 2.4 mg dose?
A: Clinical trials show that patients using 2.4 mg of semaglutide weekly can lose up to 15% of their body weight or more with proper diet and exercise.

Q: Is 2.4 mg safe to use long term?
A: Yes. This is the recommended long-term maintenance dose once your body has adjusted through titration. Many users stay on this dose for months or years with medical supervision.

Q: What if I experience side effects at this dose?
A: Side effects are most common during early use. If they persist, your provider may suggest returning to a lower dose temporarily.

Q: Can I skip doses if I reach my goal weight?
A: Wegovy is designed for ongoing weight management. Discontinuing use without a plan may lead to weight regain. Discuss options with your doctor.

Q: What happens if I miss a dose?
A: If you miss a dose and it’s been less than 5 days, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and resume your next scheduled dose.

Q: Who manufacture Wegovy?
A: Wegovy is manufactured by Novo Nordisk.

Q: Is this better than Ozempic?
A: Studies comparing Wegovy and Ozempic show both drugs are effective at helping patients diagnosed with obesity or overweight reduce their body weight, but Wegovy reduces weight more effectively than Ozempic does.

Q: Can Wegovy make you tired?
A: While Wegovy is an effective weight loss medication, it can cause side effects, including fatigue. This tiredness can result from the body adjusting to the drug, metabolic changes, or reduced caloric intake.

Q: Can Wegovy cause depression?
A: While some people taking Wegovy have reported depression or suicidal thoughts, there is no conclusive evidence to definitively say Wegovy causes depression. Some studies have shown a potential link between GLP-1 receptor agonists, like Wegovy, and psychiatric side effects, including depression and suicidal thoughts, but these findings are not conclusive.